Applying Precision Medicine in Glioblastoma: New and Emerging Therapeutic Targets

Download All
Learn how the experts are integrating new targeted therapies against NTRK and other markers in glioblastoma with downloadable slides and on-demand webcast capturing a live CCO symposium.
Andrew B. Lassman, MD
Program Director
Timothy Cloughesy, MD
Rimas V. Lukas, MD

On-Demand Webcast

In this interactive webcast capturing a live CCO symposium, experts share key data and clinical strategies for incorporating novel targeted therapies into the management of glioblastoma.

Andrew B. Lassman, MD
Program Director
Timothy Cloughesy, MD Rimas V. Lukas, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Karyopharm Therapeutics Inc.
Sumitomo Dainippon Pharma Oncology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings